EGFR T790M detection in formalin-fixed paraffin-embedded tissues of patients with lung cancer using RNA-based in situ hybridization: A preliminary feasibility study.

Abstract

BACKGROUND:

Following drug resistance in patients with lung cancer treated by EGFR TKIs, a biopsy is required to obtain sufficient cancer tissue for T790M detection in order to select potential beneficiaries suitable for third-generation EGFR TKIs, such as osimertinib. The purpose of this study was to explore the feasibility of using a new in situ analysis technique based on RNA target sequences to detect EGFR T790M in lung cancer.

METHODS:

A total of 28 formalin-fixed paraffin-embedded (FFPE) samples from 24 lung adenocarcinoma patients archived in Peking Union Medical College Hospital from 2015 to 2016 were collected. The BaseScope T790M detection technique by in situ hybridization on FFPE slides was used to analyze the mutation of EGFR T790M, and then the results were compared with the data acquired by Scorpions ARMS assay, which is the so-called gold standard for EGFR gene mutation testing. The sensitivity and specificity of the BaseScope T790M detection technique were preliminarily evaluated.

RESULTS:

Of the 28 FFPE specimens, the average proportion of T790M-positive cells was 35.78% ± 17.68% in 18 samples with EGFR T790M, confirmed by Scorpions ARMS assay, Compared with real-time PCR assay, the sensitivity and specificity of BaseScope T790M were all 100% in our cohort.

CONCLUSION:

BaseScope T790M assay could be completed on only one FFPE slide and the visualized molecular result overplayed with histomorphological information perfectly, so it may be the alternative method for EGFR T790M evaluation. BaseScope assay has potential clinical utility, and it will be necessary to carry out validation with a large number of cases.

• Authors: Shafei Wu, Xiaohua Shi, Xiaoyan Si, Yuanyuan Liu, Tao Lu, Li Zhang, Zhiyong Liang, Xuan Zeng
• Journal: Thoracic cancer (Thorac Cancer) Vol. 10 Issue 10 Pg. 1936-1944 (10 2019) ISSN: 1759-7714 [Electronic] Singapore
• PMID: 31407509 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Chemical References

• EGFR protein, human
• ErbB Receptors

Topics

• Aged
• Aged, 80 and over
• Amino Acid Substitution
• Biopsy
• ErbB Receptors (genetics)
• Female
• Humans
• Immunohistochemistry (methods, standards)
• In Situ Hybridization (methods, standards)
• Lung Neoplasms (diagnosis, genetics)
• Male
• Middle Aged
• Mutation
• Reproducibility of Results